B-
77/100
Kymera Therapeutics Claimed Company
Kymera Therapeutics is a clinical stage biopharmaceutical company pioneering a transformative new modality, “targeted protein degradation” (TPD), with the ability to pursue targets long considered undruggable and to treat disease in entirely new ways. Our team has developed a proprietary drug discovery engine, Pegasus, to enable the design of highly selective, small molecule protein degraders with potent activity against a broad range of disease indications. We are committed to selecting targets with the broadest possible impact across multiple disease indications with high unmet medical need to realize the full potential of TPD. Kymera is led by an expert team of dedicated scientists and drug hunters, with decades of experience in the foundational areas of targeted protein degradation and drug development. read more
HR or Marketing? Claim Your Free Employer Account
Kymera Therapeutics Outlook Employee Reviews
All
Positive
Constructive
What makes you most happy at work?
The collaborative team environment and the opportunities to learn and develop.
I love the atmosphere that we have here and my amazing team.
What's going wrong and how can it be improved?
There aren't any Outlook reviews of Kymera Therapeutics yet.
Be the first to contribute a review.
What do you like best about your company?
There aren't any Outlook reviews of Kymera Therapeutics yet.
Be the first to contribute a review.
What would you most like to see improved at your company?
There aren't any Outlook reviews of Kymera Therapeutics yet.
Be the first to contribute a review.
×